We use cookies and similar technologies to improve your experience, serve personalized ads, and analyze traffic. You can manage your preferences or accept/reject all.
Cookie Preferences
EssentialRequired for the site to function. Always active.
AnalyticsHelp us understand how visitors interact with the site.
AdvertisingUsed to deliver personalized ads.
FunctionalEnable enhanced functionality and personalization.
Markets · Investing · Business
Finance
This Is What I'd Do With Pfizer Stock Right Now
The pharmaceutical stock is struggling, but its dividend can be highly valuable to income investors.
Investing in a top pharmaceutical company such as Pfizer (NYSE:PFE) might seem like a good long-term hold. Unfortunately, that hasn't been the case in recent years. In the past five years, it has lost close to 40% of its value.
Many investors are torn about whether it's a good value buy or just a trap, given the question marks about its long-term future. Here's why I think the stock could be a great buy-and-hold investment right now.
Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
What moved overnight · what to watch today · pre-positioning notes from our desk. Delivered to your inbox at 6:30 AM Dubai.
No spam. Unsubscribe in one click. We never sell your email.
We use cookies and similar technologies to improve your experience, serve personalized ads, and analyze traffic. You can manage your preferences or accept/reject all.
Cookie Preferences
EssentialRequired for the site to function. Always active.
AnalyticsHelp us understand how visitors interact with the site.
AdvertisingUsed to deliver personalized ads.
FunctionalEnable enhanced functionality and personalization.